| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:23Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Tseng W.-K.; YEN-WEN WU; Ho S.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:20Z |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:18Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Yin W.-H.; Wu C.-C.; Lin S.-J.; Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
Circulating fatty-acid binding-protein 4 levels predict CV events in patients after coronary interventions
|
Chen J.-W.; Yeh H.-I.; National Taiwan Biosignature Research Investigators; Tsai H.-Y.; YEN-WEN WU; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Wang J.-H.; Chang K.-C.; Lin T.-H.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Ho S.-K.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:16Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Wu J.-R.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease
|
Huang C.-C.; Chang M.-T.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Shyur L.-F.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-15T05:23:51Z |
Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
|
Loh S.Y.; Reyes E.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Siswanto B.B.; Jaufeerally F.R.; KUO-LIONG CHIEN; Lee E.M.; Yeo P.S.D.; Poh K.K.; Chai P.; Wong C.C.R.; Santos J.; Yew K.L.; Narasimhan C.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Ngarmukos T.; Amin N.H.M.; Seng K.C.; Tan S.K.; Chan L.L.H.; Teo L.L.Y.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Park S.W.; Tan B.Y.; Lim C.P.; Lim A.; Noda T.; Nakajima I.; Lam C.S.P.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Uhm J.-S.; Kabuki T.; Kiuchi S.; Abidin I.Z.; Azmee M.G.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Wong C.K.; Liew H.B.; Arbain A.N.; Tan Y.Z.; Mojolou R.A.; Asnawi M.H.M.; Augustine A.-A.; Naik A.; Kaur D.; Sridevi C.; Raghu K.; Gopi A.; Sastry B.K.S.; Yu C.M.; Jin Q.; Ling T.; Li X.; Seo H.S.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Oh D.J.; Surarso R.; Danny S.S.; Martanto E.; Joung B.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Tedjokusumo P.; Purayil M.P.; Sharma M.K.; Sawhney J.; Mittal S.; Verma R.; Sethi H.J.S.; Kumar M.; Chopra V.; Kim E.J.; Tandon R.; Parikh K.; Chandarana A.; Shah U.; Park C.G.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Othman M.K.; Lee Y.W.; Yen C.H.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Lee M.H.; Park S.-M.; Roh S.-Y.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Hung C.-L.; Saharudin S.; Beh B.C.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Wu L.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators; Xie Y.; Rha S.W.; Chandavimol M.; Yingchoncharoen T.; Hsieh L.-C.; Hsu C.-H.; Lo P.-H.; Chen K.-W.; Hsiao L.-C.; Wang Y.-C.; Na J.O.; Lu C.-R.; Wu H.-P.; Chen K.; Lin Y.-N.; Chang S.-S.; Liang H.-Y.; Wu C.-H.; Lo L.-W.; Huang P.-H.; Chang S.-L.; Fan X.; Lin Y.-J.; Choi J.-I.; Leu H.-B.; Wang K.-L.; Sung S.-H.; Chao T.-F.; Yu W.-C.; Hsu C.-N.; Lin J.-W.; Kuo J.-Y.; Yen C.-H.; Hwang J.-J.; Shimizu W.; Kim Y.H.; KUO-LIONG CHIEN; Su T.-C.; Lin L.-Y.; Juang J.-M.; Lin Y.-H.; Chiang F.-T.; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Kim M.; Zhang S.; Hung C.-S.; Chang S.-N.; Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-03T02:28:44Z |
Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis
|
Wu T.-C.;Chen Y.-H.;Leu H.-B.;Yuh-Lien Chen;Lin F.-Y.;Lin S.-J.;Chen J.-W.; Wu T.-C.; Chen Y.-H.; Leu H.-B.; YUH-LIEN CHEN; Lin F.-Y.; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-03T02:28:43Z |
Anti-inflammatory strategies for homocysteine-related cardiovascular disease
|
Lin C.-P.; Chen Y.-H.; Leu H.-B.; Lin S.-J.; YUH-LIEN CHEN; Huang S.-L.; Chen J.-W. |
| 臺大學術典藏 |
2019 |
Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
|
Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Cheng Chang K.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Leu H.-B.; Yin W.-H.; Chen J.-W.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Cheng Chang K.; Wang J.-H.; CHAU-CHUNG WU |
| 國立臺灣大學 |
2009-12 |
Anti-inflammatory strategies for homocysteine-related cardiovascular disease.
|
Ling, C. P.; Chen, Y. H.; Leu, H. B.; Lin, S. J.; Chen, Y. L.; Huang, S. L.; , J. W. Chen. |
| 國立臺灣大學 |
2007-12 |
Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and -9 in experimental atherosclerosis.
|
Wu, T. C.; Chen, Y. H.; Leu, H. B.; Chen, Y. L.; Lin, F. Y.; Lin, S. J.; , J. W. Chen. |
